EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Effect of selective COX-2 inhibitors and non-selective non-steroidal anti-inflammatory drugs on severity of acute pancreatitis: A systematic review and meta-analysis

Alejandra Vargas, Priyata Dutta, Fadi Hawa, Elit Quingalahua, Ricardo Marin, Ana Vilela, Tyler Nix, Antonio Mendoza-Ladd, C Mel Wilcox, Jean M Chalhoub, Jorge D Machicado

Pancreatology · 2025

DOI: 10.1016/j.pan.2025.03.008 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pancreatology, 2025. Verfasst von Alejandra Vargas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Eastern Virginia Medical School, Norfolk, VA, USA. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Pancreatitis, Cyclooxygenase 2 Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: It's been suggested that non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the inflammatory response and severity of acute pancreatitis (AP). In this systematic review and meta-analysis, we aimed to explore the impact of selective COX-2 and non-selective NSAIDs compared to non-NSAID options on the severity of AP. METHODS: We searched MEDLINE, EMBASE, and Cochrane Central, from database inception through September 2023. We included RCTs and observational studies comparing NSAIDs with non-NSAID controls. The primary outcome was the development of severe acute pancreatitis (SAP) characterized by persistent organ failure lasting >48 h. Secondary outcomes included mortality, pancreatic necrosis, length of stay (LOS), pain relief, and requirement for rescue analgesia. Meta-analysis was conducted separately for selective COX-2 inhibitors and non-selective NSAIDs. RESULTS: Eleven studies met eligibility criteria including 1830 patients with AP. Of 3 studies that used selective NSAIDs (1 RCT and 2 observational), COX-2 inhibitors significantly reduced SAP (OR = 0.38; 95 %CI 0.27-0.52; p < 0.001; I2 = 0 %), pancreatic necrosis (OR = 0.48; 95 %CI 0.29-0.78; p = 0.003; I2 = 0 %), LOS by 5.51 days (95 %CI -10.80 to -0.22; p = 0.04; I2 = 97 %), and rescue opioids (OR = 0.32; 95 %CI 0.24-0.45; p < 0.001; I2 = 0 %). However, the certainty of the evidence was graded as low to very low using GRADE methodology. There was no significant effect of COX-2 inhibitors on mortality. Of 8 studies (all RCTs) that compared non-selective NSAIDs and non-NSAIDs, there was no difference in clinical outcomes, pain relief, and need for rescue analgesia. CONCLUSIONS: Selective COX-2 inhibitors potentially mitigate disease severity and shorten hospitalization in patients with AP, while non-selective NSAIDs lack this benefit. Confirmatory large-scale RCTs are warranted to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalPancreatitisCyclooxygenase 2 InhibitorsHumansAcute DiseaseSeverity of Illness Index

Stichwörter der Autor:innen

Acute pancreatitisAnalgesiaCOX-2 inhibitorCyclooxygenaseNon-steroidal anti-inflammatory drugsPainSeverity

Substanzen

Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Department of Internal Medicine, Trinity Health, Ann Arbor, MI, USA.
  • Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Pediatrics, Central Michigan University, Saginaw, MI, USA.
  • Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Division of Research and Informatics, Taubman Health Sciences Library, University of Michigan, Ann Arbor, MI, USA.

Zitieren

APA

Vargas, A., Dutta, P., Hawa, F., Quingalahua, E., Marin, R., Vilela, A., Nix, T., Mendoza-Ladd, A., Wilcox, C. M., Chalhoub, J. M., & Machicado, J. D. (2025). Effect of selective COX-2 inhibitors and non-selective non-steroidal anti-inflammatory drugs on severity of acute pancreatitis: A systematic review and meta-analysis. Pancreatology. https://doi.org/10.1016/j.pan.2025.03.008

Vancouver

Vargas A, Dutta P, Hawa F, Quingalahua E, Marin R, Vilela A, et al. Effect of selective COX-2 inhibitors and non-selective non-steroidal anti-inflammatory drugs on severity of acute pancreatitis: A systematic review and meta-analysis. Pancreatology. 2025. doi:10.1016/j.pan.2025.03.008

BibTeX
@article{Vargas2025,
  author = {Vargas, Alejandra and Dutta, Priyata and Hawa, Fadi and Quingalahua, Elit and Marin, Ricardo and Vilela, Ana and Nix, Tyler and Mendoza-Ladd, Antonio and Wilcox, C Mel and Chalhoub, Jean M and Machicado, Jorge D},
  title = {Effect of selective COX-2 inhibitors and non-selective non-steroidal anti-inflammatory drugs on severity of acute pancreatitis: A systematic review and meta-analysis},
  journal = {Pancreatology},
  year = {2025},
  doi = {10.1016/j.pan.2025.03.008}
}
Kostenlos starten →